Approvals/TGA/BEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe

Approved

STANDARD

BEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4283be49e964eee9
Product Name: BEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe
Artg Id: 397898
Artg Name: BEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2023-11-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0815d87b6f23ea340fdcf98480da1ca1.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/26da4019bd315201013cf8f2cdbeaa5f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

4283be49e964eee9

Type

Standard